CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...

North London Council announces part a partnership with telecoms infrastructure operator to deploy small cell technology ...

Aradigm Health, a new benefits platform aimed at easing the financial sting of coverage for cell and gene therapies, has ...

A foundation enrolls 100 sickle cell patients in Nigeria's NHIS to ease the financial burden of treatment and urges more ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

Jemima Goldsmith, ex-wife of jailed Pakistani leader Imran Khan, has urged Elon Musk to stop X from suppressing her posts ...

Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.

Therapy First Long-Lasting Osteoarthritis Treatment to Target All Four Major Disease Effects First-Ever Use of Donor Gum ...

A few new Ohio laws are going into effect starting in January, including a law about cell phone use in public schools and ...

Cellarity presented new preclinical data on investigational programs for sickle cell disease and myelofibrosis during the ASH Annual Meeting.

General Laka urges telecom operators, media and social platforms to join Nigeria’s kidnapping response framework to close ...